Cover Image
市場調查報告書

中風的介入神經放射學技術的全球市場

Emerging Global Market for Neurointerventional Technologies in Stroke 2014-2019

出版商 MedMarket Diligence, LLC 商品編碼 340858
出版日期 內容資訊 英文 194 Pages; 34 Exhibits
商品交期: 最快1-2個工作天內
價格
Back to Top
中風的介入神經放射學技術的全球市場 Emerging Global Market for Neurointerventional Technologies in Stroke 2014-2019
出版日期: 2015年09月30日 內容資訊: 英文 194 Pages; 34 Exhibits
簡介

本報告提供急性中風的管理相關產品及技術詳細調查、市場現狀及各國未來預測、美國、西歐、亞太地區各國等的各地區趨勢、主要企業簡介彙整。

摘要整理

第1章 全球醫療市場環境

  • 美國
  • 西歐各國
  • 亞洲主要國家:中國、印度、日本

第2章 急性中風臨床實際業務、病因、流行病學

  • 中風的病因
    • 腦出血
    • 蜘蛛網膜下腔出血
    • 缺血性中風
    • 一時性腦缺血發作

第3章 急性中風的血管內管理上的產品及技術

  • 腦出血的預防
  • 缺血性中風的預防和治療

第4章 全球血管內設備的急性中風治療管理市場

  • 腦動脈瘤和AVM栓塞系統
  • 頸動脈支架系統
  • 左心和耳閉塞系統
  • 腦血栓切除系統

第5章 企業簡介

  • Abbott Laboratories / Abbott Vascular
  • Bard C.R. / Bard Peripheral Vascular
  • Boston Scientific
  • Codman/DePuy Synthes, Cordis (Johnson & Johnson)
  • Cook Medical
  • Covidien (Medtronic)
  • Medtronic
  • MicroVention (Terumo)
  • Penumbra, Inc.
  • Stryker Corporation (covered in MD&D)
  • St. Jude Medical

附錄

圖表

目錄
Product Code: C310

This report is a detailed market and technology assessment and forecast of the products and technologies in the management of acute stroke. The report describes the epidemiology, etiology and management of hemorrhagic stroke, ischemic stroke, subarachnoid hemorrhage, and transient ischemic attack, characterizing the patient populations, their current clinical management, and trends in clinical management as new techniques and technologies are expected to be developed and emerge. The report details the currently available products and technologies, and the manufacturers offering them. The report details the products and technologies under development and markets for each in the treatment of acute stroke. The report provides a current and forecast to 2019 by region /country for the U.S., Western Europe, the major Asia-Pacific states (China, India, and Japan), and the rest of world. The report profiles the most top companies in this industry, providing status and forecast data on their current products, current market position, and products under development.

Table of Contents

EXECUTIVE SUMMARY

  • Cerebral Aneurysm and AVM Embolization Systems
  • Carotid Artery Stenting Systems
  • Left Atrial Appendage Closure Systems
  • Cerebral Thrombectomy Systems

SECTION 1: GLOBAL HEALTHCARE MARKET ENVIRONMENT

  • 1.1. United States
  • 1.2. Major Western European States
    • 1.2.1. Overview of European Healthcare: Spending, Facilities/Manpower, Reimbursement, EU Impact
    • 1.2.2. National Healthcare Profiles: France, Germany, Spain, United Kingdom
  • 1.3. Major Asian States: China, India, Japan

SECTION 2: CLINICAL PRACTICE, ETIOLOGY AND EPIDEMIOLOGY OF ACUTE STROKE

  • 2.1. Etiology of Stroke
    • 2.1.1. Hemorrhagic Stroke
      • 2.1.1.1. Intracerebral Hemorrhage
      • 2.1.1.2. Causes, Risk Factors and Common Symptoms
      • 2.1.1.3. Management of Acute ICH
    • 2.1.2. Subarachnoid Hemorrhage
      • 2.1.2.1. Causes, Risk Factors and Common Symptoms of SAH
      • 2.1.2.2. Diagnostic and Therapeutic Management of SAH
    • 2.1.3. Ischemic Stroke
      • 2.1.3.1. Thrombotic Stroke - Causes & Mechanisms
      • 2.1.3.2. Embolic Stroke - Causes & Mechanisms
      • 2.1.3.3. Hypoperfusion Stroke - Causes & Mechanisms
      • 2.1.3.4. Symptoms and Risk Factors for Ischemic Stroke
      • 2.1.3.5. Management of Acute Ischemic Stroke
        • 2.1.3.5.1. Ischemic Stroke Diagnostics
        • 2.1.3.5.2. Therapeutic Management of Cerebral Ischemia
    • 2.1.4. Transient Ischemic Attack

SECTION 3: PRODUCTS, TECHNOLOGIES, AND TECHNIQUES IN THE ENDOVASCULAR MANAGEMENT OF ACUTE STROKE

  • 3.1. Prophylaxis of Hemorrhagic Stroke
    • 3.1.1. Treatment of Cerebral Aneurysms and AVMs
      • 3.1.1.1. Surgical Repair of Cerebral Aneurysms and AVMs
      • 3.1.1.2. Endovascular Embolization of Cerebral Aneurysms and AVMs
        • 3.1.1.2.1. Microcoil Systems
        • 3.1.1.2.2. Liquid Embolic Systems
        • 3.1.1.2.3. Embolization Assisting Stenting Systems
        • 3.1.1.2.4. Flow Diverting Embolization Systems
        • 3.1.1.2.5. Cerebral Aneurysm & AVM Embolization Procedure Volumes
  • 3.2. Prophylaxis and Treatment of Ischemic Stroke
    • 3.2.1. Treatment of Advanced Carotid Artery Stenosis
      • 3.2.1.1. Carotid Endarterectomy
        • 3.2.1.1.1. Carotid Artery Stenting
        • 3.2.1.1.2. CREST Trial Results
        • 3.2.1.1.3. Carotid Stenting Procedure Volumes
    • 3.2.2. Left Atrial Appendage Closure Systems
      • 3.2.2.1. Surgical Closure of Left Atrial Appendage
      • 3.2.2.2. Endovascular Closure of Left Atrial Appendage
        • 3.2.2.2.1. Accumulated Clinical Experience with Endovascular LAA Closure Systems
        • 3.2.2.2.2. Left Atrial Appendage Endovascular Closure Procedure Volumes
    • 3.2.3. Cerebral Thrombectomy Systems
      • 3.2.3.1. Accumulated Clinical Experience with Cerebral Thrombectomy Systems
      • 3.2.3.2. Cerebral Thrombectomy Procedure Volumes
        • 3.2.3.2.1. Intracranial Stenting Systems
    • 3.2.4. Accumulated Clinical Experience with Intracranial Stents

SECTION 4: GLOBAL EMERGING MARKET FOR ENDOVASCULAR DEVICE-BASED ACUTE STROKE THERAPEUTIC MANAGEMENT

  • 4.1. Cerebral Aneurysm and AVM Embolization Systems
    • 4.1.1. Industry Product Offering
      • 4.1.1.1. Embolics and Associated Delivery Devices
      • 4.1.1.2. Coil Containing Stents
      • 4.1.1.3. Flow Diversion Systems
    • 4.1.2. Market Forecast
      • 4.1.2.1. Competitive Analysis
  • 4.2. Carotid Stenting Systems
    • 4.2.1. Industry Product Offering
      • 4.2.1.1. Emerging Carotid Artery Stenting Technologies
        • 4.2.1.1.1. Flow Reversal Neuroprotection Systems
        • 4.2.1.1.2. Covered Carotid Stenting Systems
    • 4.2.2. Market Forecast
      • 4.2.2.1. Competitive Analysis
  • 4.3. Left Atrial Appendage Closure Systems
    • 4.3.1. Left Atrial Appendage Closure Systems on the Market
    • 4.3.2. Worldwide Market for Endovascular Left Atrial Appendage Closure Systems
      • 4.3.2.1. Suppliers Market Shares
  • 4.4. Cerebral Thrombectomy Systems for Acute Ischemic Stroke Management
    • 4.4.1. Cerebral Thrombectomy Systems on the Market
    • 4.4.2. Cerebral Thrombectomy Product Market
      • 4.4.2.1. Competitive Analysis

SECTION 5: COMPANY PROFILES

  • 5.1. Abbott Laboratories / Abbott Vascular
  • 5.2. Bard C.R. / Bard Peripheral Vascular
  • 5.3. Boston Scientific
  • 5.4. Codman/DePuy Synthes, Cordis (Johnson & Johnson)
  • 5.5. Cook Medical
  • 5.6. Covidien (Medtronic)
  • 5.7. Medtronic
  • 5.8. MicroVention (Terumo)
  • 5.9. Penumbra, Inc.
  • 5.10. Stryker Corporation (covered in MD&D)
  • 5.11. St. Jude Medical

APPENDIX: COMPANY LISTING

List of Exhibits

  • Exhibit ES-1: Projected Dynamics of Endovascular Acute Stroke Management Procedures, 2013-2019 (#000)
  • Exhibit ES-2 Projected Dynamics of Endovascular Acute Stroke Management Product Market, 2013-2019 ($ mil)
  • Exhibit ES-3: Projected Dynamics of the Global Cerebral Endovascular Embolization Product Market, 2013-2019
  • Exhibit ES-4: Projected Dynamics of Distally Protected Carotid Artery Stenting Market, 2014-2019
  • Exhibit ES-5: Projected Dynamics of the Global Left Atrial Appendage Endovascular Closure Product Market, 2013-2019
  • Exhibit ES-6: Projected Dynamics of the Global Cerebral Thrombectomy Product Market, 2013-2019
  • Exhibit 1-1: United States, Selected Healthcare/Public Health Indicators, 2014
  • Exhibit 1-2: France, Selected Healthcare/Public Health Indicators, 2014
  • Exhibit 1-3: Germany, Selected Healthcare/Public Health Indicators, 2014
  • Exhibit 1-4: Italy, Selected Healthcare/Public Health Indicators, 2014
  • Exhibit 1-5: Spain, Selected Healthcare/Public Health Indicators, 2014
  • Exhibit 1-6: United Kingdom, Selected Healthcare/Public Health Indicators, 2014
  • Exhibit 1-7: China, Selected Healthcare/Public Health Indicators, 2014
  • Exhibit 1-8: India, Selected Healthcare/Public Health Indicators, 2014
  • Exhibit 1-9: Japan, Selected Healthcare/Public Health Indicators, 2014
  • Exhibit 2-1: Clinical Features and Characteristics of Hemorrhagic Stroke
  • Exhibit 2-2: Clinical Features and Characteristics of Ischemic Stroke
  • Exhibit 3-1: Findings from Clinical Trials with the Use of Flow Diversion Devices in Treatment of Large, Giant, and Wide Neck Intracranial Aneurysms
  • Exhibit 3-2: Projected Dynamics of Cerebral Endovascular Embolization Procedures 2013-2019 (#000)
  • Exhibit 3-3: Projected Dynamics of Protected Carotid Stenting Procedures, 2013-2019 (#000)
  • Exhibit 3-4: Long-Term Clinical Outcomes of Surgical Left Atrial Appendage (LAA) Closure
  • Exhibit 3-5: Findings from Selected Clinical Trials with Endovascular LAA Closure Systems
  • Exhibit 3-6: Projected Dynamics of Left Atrial Appendage Closure Procedures, 2013-2019 (#000)
  • Exhibit 3-7: Findings from Major Clinical Trials with Cerebral Thrombectomy Systems
  • Exhibit 3-7: Projected Dynamics of Cerebral Thrombectomy Procedures, 2013-2019 (#000)
  • Exhibit 4-1: Projected Dynamics of Endovascular Acute Stroke Management Procedures, 2013-2019 (#000)
  • Exhibit 4-2: Projected Dynamics of Endovascular Acute Stroke Management Product Market, 2013-2019 ($ mil)
  • Exhibit 4-3: Selected Industry Product Offering in Cerebral Aneurysm & AVM Embolics and Associated Delivery Devices
  • Exhibit 4-4: Selected Industry Product Offering in Coil Containing Stenting Devices
  • Exhibit 4-5: Selected Industry Product Offering in Flow Diversion Devices
  • Exhibit 4-6: Projected Dynamics of Global Intracranial Aneurysm and AVM Endovascular Embolization Product Market, 2013-2019
  • Exhibit 4-7: Estimated Global Market Shares of the Leading Suppliers of Neurovascular Embolization Systems, 2014
  • Exhibit 4-8: Selected Industry Product Offering in Carotid Artery Stenting and Distal Protection Systems
  • Exhibit 4-9: Projected Dynamics of Distally Protected Carotid Artery Stenting Market, 2014-2019
  • Exhibit 4-10: Estimated 2014 Global Market Shares of the Leading Suppliers of Distally Protected Carotid Artery Stenting Systems
  • Exhibit 4-11: Selected Industry Product Offering in Endovascular LAA Closure Systems
  • Exhibit 4-12: Projected Dynamics of Left Atrial Appendage Closure Procedures/Product Sales, 2013-2019 (#000/$mil)
  • Exhibit 4-13: Estimated 2014 Global Market Shares of the Leading Suppliers of LAA Closure Systems
  • Exhibit 4-14: Selected Cerebral Thrombectomy Systems on the U.S. and International Markets
  • Exhibit 4-15: Projected Dynamics of Cerebral Thrombectomy Product Market, 2013-2019
Back to Top